№ files_lp_3_process_9_36076
File format: docx
Character count: 5413
File size: 1017 KB
Comprehensive informational source detailing signs, symptoms, and risk factors of Polycystic Ovary Syndrome, including diagnostic criteria, prevalence statistics, and guidance for consulting healthcare professionals.
Year:
2026
Region / City:
Australia
Document Type:
Informational Article
Organization / Institution:
The PCOS Clinic
Author:
Dr. Rebecca Harwin
Target Audience:
Women of reproductive age
Symptoms Covered:
Irregular menstruation, high testosterone, polycystic ovaries, acne, hirsutism, overweight/obesity, infertility, hair loss, skin changes, fatigue, mood disorders
Medical Focus:
Polycystic Ovary Syndrome (PCOS)
Diagnosis Criteria:
Menstrual irregularities, androgen levels, ultrasound findings, insulin resistance
Consultation Information:
PCOS Discovery Session via The PCOS Clinic
References:
www.ConquerYourPCOSNaturally.com
Note:
, www.ThePCOSClinic.com
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Version:
1.5.0.0
Protocol Posting Date:
June 2024
CAP Laboratory Accreditation Program Protocol Required Use Date:
March 2025
Authors:
Gulisa Turashvili, MD, PhD; Uma G. Krishnamurti, MD, PhD; Barbara A. Crothers, DO; Giovanna A. Giannico, MD; Krisztina Hanley, MD; Anna Plotkin, MD; Anthony N. Karnezis, MD, PhD.
Note:
Accreditation Requirements
Date of Protocol Posting:
June 2024
Date of Required Use:
March 2025
Year:
2024
Region / city:
United Kingdom
Topic:
Health, Medical Condition
Document Type:
Patient Information Leaflet
Organization / Institution:
BritSPAG Executive Committee
Author:
BritSPAG Executive Committee
Target Audience:
Teenagers, young adults, individuals with PCOS or at risk
Period of validity:
Ongoing
Approval Date:
January 2024
Date of amendments:
Not specified
Contextual description:
Information leaflet explaining polycystic ovary syndrome (PCOS) in teenagers and young adults, with details on symptoms, diagnosis, treatment options, and resources for support.
Year:
2026
Databases:
PubMed, Embase, Cochrane Library, Web of Science
Topic:
Polycystic ovary syndrome, depression, anxiety
Document type:
Supplementary table
Author:
Not specified
Target population:
Patients with polycystic ovary syndrome and comorbid mental health conditions
Search period:
Up to 2026
Query type:
MeSH terms and title/abstract keywords
Number of results:
PubMed 7631, Embase 24191, Cochrane Library 2611, Web of Science 1114
Year:
2026
Institution:
S. Lal Singh Memorial College of Pharmacy (DBU)
Author:
Ruvaita Showakat
Document Type:
Review Article
Target Audience:
Medical students, healthcare professionals
Condition:
Polycystic Ovary Syndrome (PCOS)
Diagnostic Criteria:
Rotterdam criteria
Management Strategies:
Lifestyle modification, pharmacological therapy
Research Gaps:
Genetic and epigenetic factors, long-term treatment outcomes, population diversity
Future Directions:
Personalized medicine, digital health integration, holistic care
Year:
2021
Region:
Australia
Topic:
Pharmacology / Drug utilisation
Document type:
Report
Organization:
Drug Utilisation Sub-Committee (DUSC), Department of Health, Services Australia
Drug:
Tolvaptan
Condition:
Autosomal dominant polycystic kidney disease (ADPKD)
Population:
Adults with chronic kidney disease stage 1–3
Data source:
Pharmaceutical Benefits Scheme (PBS) database
Date of PBS listing:
1 January 2019
Treatment criteria:
Nephrologist management, eGFR 30–89 mL/min/1.73m², evidence of rapidly progressing disease
Monitoring requirements:
Liver function tests prior to initiation, monthly for 18 months, then every 3 months
Dosage forms:
15 mg, 30 mg, 45 mg, 60 mg, 90 mg tablets in split-dose regimens
Analysis period:
First and second year of PBS listing
Year:
2024
Region / city:
United Kingdom
Topic:
Health, Medical Condition
Document Type:
Patient Information Leaflet
Organization / Institution:
BritSPAG Executive Committee
Author:
BritSPAG Executive Committee
Target Audience:
Teenagers, young adults, individuals with PCOS or at risk
Period of validity:
Ongoing
Approval Date:
January 2024
Date of amendments:
Not specified
Contextual description:
Information leaflet explaining polycystic ovary syndrome (PCOS) in teenagers and young adults, with details on symptoms, diagnosis, treatment options, and resources for support.
Note:
Year
Topic:
Medical Necessity for Genetic Testing
Document Type:
Letter
Target Audience:
Medical Director
Year:
2026
Databases:
PubMed, Embase, Cochrane Library, Web of Science
Topic:
Polycystic ovary syndrome, depression, anxiety
Document type:
Supplementary table
Author:
Not specified
Target population:
Patients with polycystic ovary syndrome and comorbid mental health conditions
Search period:
Up to 2026
Query type:
MeSH terms and title/abstract keywords
Number of results:
PubMed 7631, Embase 24191, Cochrane Library 2611, Web of Science 1114
Year:
2026
Institution:
S. Lal Singh Memorial College of Pharmacy (DBU)
Author:
Ruvaita Showakat
Document Type:
Review Article
Target Audience:
Medical students, healthcare professionals
Condition:
Polycystic Ovary Syndrome (PCOS)
Diagnostic Criteria:
Rotterdam criteria
Management Strategies:
Lifestyle modification, pharmacological therapy
Research Gaps:
Genetic and epigenetic factors, long-term treatment outcomes, population diversity
Future Directions:
Personalized medicine, digital health integration, holistic care
Year:
2017
Region / City:
Fredericksburg, VA
Topic:
Medical Equipment Procurement
Document Type:
Combined Synopsis/Solicitation
Organization:
U.S. Department of Veterans Affairs
Author:
Sonja Davis
Target Audience:
Vendors, Contractors
Period of Validity:
2017-2020
Approval Date:
03-29-2017
Date of Amendments:
N/A
Year:
2022
Region / City:
Canberra
Topic:
Vital signs monitoring, early warning scores
Document type:
Procedure
Institution:
North Canberra Hospital
Author:
Not specified
Target audience:
Clinical staff at North Canberra Hospital
Period of validity:
Ongoing
Approval date:
Not specified
Amendment date:
Not specified
Year:
Not specified
Topic:
Health, Clinical Assessment, Vital Signs
Document Type:
Educational Quiz / Training Module
Target Audience:
Medical assistants, nursing students, healthcare trainees
Sections:
Multiple-choice questions
Content Focus:
Blood pressure, respiration, temperature, pulse, BMI, fainting, hypertension, tachycardia
Year:
2022
Region / City:
Brussels
Topic:
Sustainability Linked Loan
Document Type:
Press Release
Organization / Institution:
Umicore, BNP Paribas Fortis
Author:
Filip Platteeuw
Target Audience:
Financial and corporate professionals, investors
Effective Period:
2022-2025
Approval Date:
10 February 2022
Modification Date:
Not specified
Year:
2014
Region / City:
Brisbane
Subject:
Traffic Control, Road Infrastructure
Document Type:
Technical Specification
Authority:
Brisbane City Council
Author:
Brisbane City Council
Target Audience:
Contractors, Engineers, Road Safety Authorities
Effective Period:
Ongoing
Approval Date:
Apr 2014
Amendment Dates:
May 2016, Mar 2021
Date of Latest Changes:
Mar 2021
Year:
2017
Region / City:
Fredericksburg, VA
Subject:
Veterans Affairs, Medical Equipment Procurement
Type of Document:
Combined Synopsis/Solicitation
Organization:
U.S. Department of Veterans Affairs, Strategic Acquisition Center
Author:
Sonja Davis
Target Audience:
Contractors, Suppliers
Period of Validity:
2017-2018
Approval Date:
May 29, 2017
Modification Date:
N/A
Year:
2021
Region / City:
Not specified
Topic:
Augmentative and Alternative Communication (AAC)
Document Type:
Article
Organization / Institution:
Not specified
Author:
Rachel Madel M.A., CCC-SLP, Chris Bugaj M.A., CCC-SLP
Target Audience:
Parents, Educators, Therapists
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Canberra
Theme:
Healthcare, Clinical Guidelines
Document Type:
Procedure
Organization:
Canberra Health Services
Author:
Not specified
Target Audience:
Clinicians, Medical Officers, Nurses, Allied Health Professionals
Period of validity:
Not specified
Approval Date:
Not specified
Date of Amendments:
Not specified
Note:
Year
Document type:
Health tracking form
Target audience:
Healthcare providers
Year:
2020
Region / city:
Rome
Topic:
Religious reflection, Salesian spirituality
Document type:
Pastoral letter
Institution:
Salesian Congregation
Author:
Rector Major
Target audience:
Salesians
Period of validity:
2020-2026
Approval date:
8 December 2020
Date of changes:
None
Year:
2017
Note:
Region / City
Theme:
Cardiovascular and Pulmonary Health, Physical Therapy
Document Type:
Clinical Guidelines
Organization / Institution:
American College of Sports Medicine (ACSM)
Target Audience:
Healthcare professionals, physical therapists
Date of Amendments:
2017 (revised)